�Ӱ���Ƶ

The brainchild of John Wang, PhD, Co-Leader of Case CCC's Cancer Genomics and Epigenomics Program, the Emerging Researchers Program welcomed four returning students and two new students this week—all from East Cleveland. With the support of Frances Payne Bolton School of Nursing, CWRU's Faye Gary, ...

University Hospitals Newsroom CLEVELAND – Data from a new study published in NEJM Evidence shows promise for personalized use of short term ADT in men with predominantly intermediate-risk prostate cancer. The study involved ArteraAI, a developer of multimodal artificial intelligence-based predictiv...

A new three-year, $2.5 million grant from Stand Up To Cancer® (SU2C) has been awarded to a multi-institutional team of gastroesophageal cancer experts, led by Anil K. Rustgi, MD, director of the Herbert Irving Comprehensive Cancer Center (HICCC) at NewYork-Presbyterian/Columbia University Irving Med...

A standing-room-only audience of Cleveland high school students and their families attended orientation for the 20th Annual Scientific Enrichment and Opportunity (SEO) and Youth Engaged in Science (YES) programs on June 5. Students were treated to an inspirational and motivational address by Edward ...

Case CCC proudly introduces the 2023 cohort of CanSUR Scholars. These diverse students from universities across the nation begin training in Cleveland at the end of May. Directed by Mark Jackson, PhD, Associate Director for Cancer Training and Education, the program this year attracted 320 applicat...

Agata Exner, PhD, co-leader of Case CCC's Cancer Imaging Program and Associate Director of CWRU SOM's Medical Scientist Training Program, was featured in Newswise on April 11 with postdoc Pinunta "Petch" Nittayacharn for their work using tiny bubbles to make mRNA more effective. Nittayacharn recent...

Move over, Big Apple! While Cleveland might not have Times Square, it isn't lacking in the welcome department. Electronic billboards at Cleveland Hopkins International Airport greeted Gary Schwartz, MD, even before his official first day as Case CCC director. Schwartz, who hails from New York and m...

Research originating from the lab of Quintin Pan, PhD, co-leader of Case CCC's Molecular Oncology Program, was featured last week on cleveland.com. It was reported that the two drugs on which his lab is working are likely to stop HPV from causing cancer. Pan suggests that, even if the virus can't b...

In a paper published in Genes & Development, investigators identified the protein WRD5 as a promising way to turn off cancer “stemness” at a molecular level, clearing the way for treatment like chemotherapy to kill glioblastoma cells. Cancer stem cells, like regular stem cells, can inherently repair...

�Ӱ���Ƶ has completed an exclusive license agreement with Atlanta-based RORA Biologics Inc. (RORA-Bio) for intellectual property to develop new therapies to treat HIV and certain kinds of cancer. The agreement gives RORA-Bio exclusive international rights to T-cell memory st...